This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
trigram | frequency |
---|---|
stem cell transplantation | 1488 |
as well as | 1348 |
in patients with | 1179 |
the presence of | 1010 |
cd t cells | 981 |
the use of | 937 |
the number of | 855 |
in order to | 782 |
hematopoietic stem cell | 688 |
a total of | 628 |
the development of | 613 |
cd t cell | 570 |
of the patients | 569 |
in this study | 566 |
of patients with | 528 |
conflict of interest | 524 |
of this study | 493 |
the risk of | 485 |
background case studies | 481 |
one of the | 480 |
of conflict of | 479 |
disclosure of conflict | 479 |
the aim of | 469 |
study was to | 455 |
the role of | 452 |
mhc class i | 451 |
the incidence of | 445 |
is associated with | 427 |
due to the | 425 |
cd and cd | 421 |
according to the | 410 |
based on the | 410 |
to evaluate the | 391 |
study design method | 387 |
the time of | 387 |
there was no | 385 |
with a median | 384 |
the effect of | 382 |
this study was | 381 |
for patients with | 379 |
allogeneic stem cell | 373 |
to determine the | 370 |
the expression of | 363 |
in the presence | 352 |
red blood cells | 344 |
at the time | 343 |
the majority of | 340 |
of the study | 339 |
the absence of | 338 |
aim of this | 325 |
was associated with | 324 |
the treatment of | 317 |
nothing to declare | 316 |
allogeneic hematopoietic stem | 315 |
a median of | 314 |
compared to the | 310 |
was used to | 309 |
the most common | 309 |
hla class i | 306 |
the impact of | 302 |
found to be | 299 |
the frequency of | 293 |
associated with a | 292 |
was observed in | 285 |
a median follow | 285 |
t cell responses | 283 |
red blood cell | 276 |
cumulative incidence of | 270 |
peripheral blood stem | 267 |
cells in the | 266 |
as compared to | 262 |
the outcome of | 256 |
in terms of | 256 |
by flow cytometry | 253 |
aim of the | 253 |
in the first | 253 |
t cells in | 252 |
in addition to | 251 |
it has been | 248 |
there were no | 244 |
t cell epitopes | 242 |
the results of | 242 |
been shown to | 241 |
patients who received | 241 |
role in the | 240 |
to assess the | 239 |
versus host disease | 238 |
graft versus host | 238 |
mhc class ii | 236 |
there is a | 236 |
a number of | 236 |
there was a | 235 |
in response to | 229 |
well as the | 229 |
at a median | 227 |
we found that | 225 |
were treated with | 224 |
bone marrow transplantation | 222 |
median age was | 218 |
of t cell | 214 |
and in the | 214 |
autologous stem cell | 213 |
specific cd t | 213 |
associated with the | 211 |
in the absence | 211 |
to investigate the | 211 |
analysis of the | 210 |
the immune system | 209 |
of cd t | 207 |
of the blood | 207 |
the median age | 206 |
was found to | 206 |
of the disease | 205 |
morbidity and mortality | 204 |
t cells were | 204 |
the quality of | 204 |
median age of | 203 |
and cd t | 202 |
in patients who | 200 |
the need for | 199 |
t cells and | 198 |
of blood components | 198 |
involved in the | 197 |
the percentage of | 196 |
in all patients | 195 |
included in the | 192 |
the prevalence of | 191 |
before and after | 190 |
of t cells | 187 |
an increase in | 187 |
median time to | 187 |
the most frequent | 186 |
at least one | 186 |
major histocompatibility complex | 186 |
the end of | 185 |
in both groups | 185 |
class i molecules | 184 |
acute myeloid leukemia | 184 |
has been shown | 184 |
were used to | 183 |
stem cell transplant | 183 |
the production of | 182 |
in the study | 182 |
the efficacy of | 180 |
the level of | 180 |
the t cell | 179 |
of cd cells | 178 |
there is no | 177 |
t cell receptor | 177 |
the detection of | 174 |
was performed using | 174 |
patients with a | 173 |
of the immune | 173 |
has not been | 173 |
were included in | 172 |
to be a | 172 |
of blood donors | 171 |
no significant difference | 171 |
is the most | 170 |
the median time | 170 |
of blood products | 170 |
be associated with | 169 |
were associated with | 169 |
the context of | 169 |
stem cell source | 168 |
study is to | 168 |
can be used | 168 |
severe acute respiratory | 166 |
was performed by | 166 |
the induction of | 165 |
in combination with | 164 |
most of the | 164 |
acute respiratory syndrome | 164 |
the rate of | 164 |
weak d type | 164 |
in the context | 163 |
are associated with | 163 |
the importance of | 163 |
reduced intensity conditioning | 163 |
because of the | 162 |
shown to be | 162 |
be used to | 162 |
the immune response | 162 |
increase in the | 161 |
the identification of | 161 |
between the two | 161 |
median follow up | 160 |
data suggest that | 159 |
blood stem cell | 159 |
blood stem cells | 159 |
risk factors for | 158 |
to reduce the | 157 |
the pathogenesis of | 157 |
part of the | 157 |
of patients who | 156 |
expression of the | 155 |
as a result | 155 |
all patients received | 155 |
with or without | 155 |
the present study | 155 |
in case of | 154 |
of these patients | 154 |
age was years | 154 |
umbilical cord blood | 154 |
the diagnosis of | 153 |
the lack of | 153 |
class i and | 153 |
the blood bank | 153 |
median age at | 153 |
was significantly higher | 151 |
was found in | 151 |
patients in the | 150 |
was performed in | 150 |
patients who underwent | 149 |
the conditioning regimen | 149 |
this study is | 149 |
is one of | 149 |
on the other | 149 |
hematopoietic cell transplantation | 148 |
of the hla | 148 |
was detected in | 147 |
t cell response | 146 |
all patients were | 146 |
the effects of | 146 |
an important role | 145 |
the ability of | 145 |
in of patients | 145 |
has been reported | 145 |
none of the | 145 |
have been reported | 144 |
the course of | 144 |
memory t cells | 143 |
specific t cells | 143 |
up of months | 142 |
in the treatment | 142 |
results suggest that | 141 |
of the most | 141 |
significantly higher in | 141 |
related to the | 141 |
were detected in | 141 |
in children with | 141 |
blood and blood | 141 |
the purpose of | 140 |
median number of | 140 |
with respect to | 140 |
t cell clones | 140 |
total number of | 139 |
of blood transfusion | 139 |
of the patient | 139 |
the ability to | 139 |
have shown that | 139 |
mg kg day | 139 |
significant difference in | 139 |
when compared to | 139 |
patients treated with | 139 |
hla class ii | 138 |
study design methods | 138 |
quality of life | 138 |
important role in | 137 |
and chronic gvhd | 136 |
in the blood | 136 |
the two groups | 135 |
for the treatment | 135 |
patients with severe | 135 |
the other hand | 134 |
acute and chronic | 134 |
was defined as | 133 |
median time of | 133 |
were able to | 133 |
of acute gvhd | 132 |
total of patients | 132 |
a and b | 132 |
the implementation of | 132 |
after a median | 131 |
was used for | 131 |
in comparison to | 131 |
were found in | 131 |
to study the | 130 |
the proportion of | 130 |
were found to | 130 |
human leukocyte antigen | 129 |
of whole blood | 129 |
from patients with | 129 |
in of the | 129 |
for the first | 129 |
in contrast to | 128 |
the addition of | 128 |
was determined by | 127 |
the activation of | 127 |
is based on | 127 |
the study was | 127 |
in these patients | 126 |
in the last | 125 |
years of age | 125 |
the control group | 125 |
patients who had | 124 |
during the first | 124 |
the surface of | 124 |
number of patients | 124 |
patients with acute | 124 |
the cumulative incidence | 123 |
used as a | 123 |
present in the | 122 |
used in the | 122 |
the case of | 122 |
was carried out | 122 |
a combination of | 122 |
t cells from | 122 |
risk factor for | 122 |
a result of | 122 |
high levels of | 122 |
to identify the | 122 |
in the control | 121 |
was to evaluate | 121 |
of mhc class | 121 |
appears to be | 120 |
follow up of | 120 |
are needed to | 120 |
the patient was | 120 |
of the cd | 120 |
showed that the | 120 |
haematopoietic stem cell | 120 |
acute lymphoblastic leukemia | 120 |
a role in | 119 |
immune response to | 119 |
number of cd | 119 |
a variety of | 119 |
we conclude that | 118 |
the amount of | 118 |
resulted in a | 118 |
t cell activation | 118 |
due to a | 117 |
the patients with | 117 |
seems to be | 117 |
in our study | 117 |
expression of cd | 117 |
differences in the | 117 |
of the sars | 116 |
the fact that | 116 |
the generation of | 116 |
the basis of | 116 |
no significant differences | 116 |
in peripheral blood | 116 |
in blood donors | 116 |
were tested for | 116 |
were observed in | 115 |
t cells are | 115 |
increased risk of | 114 |
of blood and | 114 |
analysis was performed | 114 |
the introduction of | 114 |
cell transplantation in | 113 |
was used in | 113 |
the occurrence of | 113 |
the patients who | 113 |
a panel of | 113 |
found in the | 112 |
with a high | 112 |
the age of | 112 |
and overall survival | 111 |
significantly associated with | 111 |
suggest that the | 111 |
at time of | 111 |
as part of | 111 |
group of patients | 110 |
specific t cell | 110 |
in the group | 110 |
we investigated the | 110 |
regulatory t cells | 109 |
an average of | 109 |
used for the | 109 |
at the end | 108 |
at room temperature | 108 |
for the development | 108 |
cytotoxic t lymphocytes | 108 |
could not be | 108 |
was seen in | 108 |
in all cases | 107 |
the management of | 107 |
out of patients | 107 |
in our center | 107 |
in transfusion medicine | 107 |
the most important | 107 |
blood transfusion service | 106 |
of patients were | 106 |
a decrease in | 106 |
the safety of | 106 |
hematopoietic stem cells | 106 |
median of days | 106 |
in vitro and | 105 |
associated with increased | 105 |
on the surface | 105 |
in the present | 105 |
at our institution | 105 |
to analyze the | 105 |
of red blood | 105 |
we analyzed the | 105 |
a patient with | 105 |
were used for | 105 |
the total number | 104 |
after allogeneic hematopoietic | 104 |
been associated with | 104 |
in patients undergoing | 104 |
conditioning regimen was | 103 |
of cd and | 103 |
total body irradiation | 103 |
at the same | 103 |
in the same | 103 |
for the detection | 103 |
in the number | 103 |
the objective of | 102 |
a median age | 102 |
each of the | 102 |
observed in the | 102 |
human immunodeficiency virus | 102 |
was performed on | 102 |
and bone marrow | 101 |
contribute to the | 101 |
the cell surface | 101 |
age of years | 101 |
was significantly lower | 101 |
to compare the | 100 |
the levels of | 100 |
t cell epitope | 100 |
and safety of | 100 |
in the pathogenesis | 100 |
is characterized by | 100 |
incidence of relapse | 99 |
between january and | 99 |
the type of | 99 |
of our study | 99 |
and of the | 99 |
year overall survival | 99 |
is the first | 99 |
patients with high | 99 |
be due to | 99 |
difference in the | 99 |
this is a | 99 |
in complete remission | 98 |
of stem cells | 98 |
in the development | 98 |
were performed in | 98 |
shown in table | 98 |
patients received a | 98 |
the setting of | 97 |
majority of patients | 97 |
of the t | 97 |
may be a | 97 |
results of the | 97 |
of hla class | 97 |
we show that | 97 |
sickle cell disease | 97 |
on the basis | 97 |
blood samples were | 96 |
in the setting | 96 |
compared with the | 96 |
use of the | 96 |
derived from the | 96 |
was used as | 96 |
cohort of patients | 96 |
this study we | 96 |
have been shown | 96 |
in multivariate analysis | 95 |
end of the | 95 |
detected in the | 95 |
to have a | 95 |
results indicate that | 95 |
in the case | 94 |
not associated with | 94 |
should be considered | 94 |
such as the | 94 |
of the donor | 94 |
some of the | 94 |
the analysis of | 94 |
did not differ | 94 |
a median time | 94 |
the mhc class | 93 |
depending on the | 93 |
the possibility of | 93 |
this is the | 93 |
iv acute gvhd | 93 |
no difference in | 93 |
in out of | 93 |
was assessed by | 92 |
incidence of acute | 92 |
are shown in | 92 |
play a role | 92 |
on day and | 92 |
of the total | 91 |
matched unrelated donor | 91 |
their ability to | 91 |
to determine whether | 91 |
to improve the | 91 |
understanding of the | 91 |
gd t cells | 91 |
fresh frozen plasma | 91 |
in the early | 91 |
the same time | 91 |
the severity of | 91 |
to be associated | 90 |
were used as | 90 |
class ii molecules | 90 |
prior to the | 90 |
were obtained from | 90 |
more likely to | 90 |
known to be | 90 |
to be the | 90 |
higher in the | 90 |
patients who were | 90 |
a group of | 90 |
t cells with | 90 |
who did not | 90 |
i and ii | 90 |
after allogeneic stem | 90 |
the combination of | 89 |
the onset of | 89 |
in a single | 89 |
the distribution of | 89 |
we observed a | 89 |
the median follow | 89 |
is an important | 89 |
patients with aml | 89 |
are able to | 89 |
the patients were | 89 |
memory cd t | 89 |
significant differences in | 89 |
in comparison with | 89 |
safety and efficacy | 88 |
it is not | 88 |
a series of | 88 |
peripheral blood mononuclear | 88 |
need to be | 88 |
were collected from | 88 |
that can be | 88 |
to increase the | 88 |
the last years | 88 |
d and d | 88 |
the availability of | 87 |
has also been | 87 |
associated with an | 87 |
patients were treated | 87 |
was higher in | 87 |
of peripheral blood | 87 |
neutrophil and platelet | 87 |
the first time | 87 |
of the donors | 87 |
influenza a virus | 86 |
purpose of this | 86 |
compared to those | 86 |
but not in | 86 |
was performed with | 86 |
a history of | 86 |
objective of this | 86 |
of nk cells | 86 |
safe and effective | 85 |
of the human | 85 |
cell responses to | 85 |
response to the | 85 |
these results suggest | 85 |
blood mononuclear cells | 85 |
of the virus | 85 |
patients had a | 85 |
was no significant | 85 |
than in the | 84 |
the association of | 84 |
a retrospective study | 84 |
we report the | 84 |
in the table | 84 |
in the future | 84 |
the regulation of | 84 |
one or more | 84 |
t cell proliferation | 84 |
blood group system | 84 |
can lead to | 84 |
is a major | 84 |
of the peptide | 84 |
we performed a | 84 |
of the first | 84 |
of chronic gvhd | 84 |
of bone marrow | 84 |
the duration of | 83 |
blood donors in | 83 |
occurred in patients | 83 |
balb c mice | 83 |
in t cell | 83 |
and in vivo | 83 |
of them were | 83 |
it is possible | 83 |
of blood donation | 83 |
is a rare | 82 |
these data suggest | 82 |
cell transplantation for | 82 |
well as in | 82 |
were analyzed by | 82 |
central nervous system | 82 |
high risk of | 82 |
evaluation of the | 82 |
obtained from the | 82 |
a subset of | 82 |
development of a | 82 |
results show that | 82 |
were used in | 82 |
the first year | 82 |
a cohort of | 82 |
as shown in | 82 |
use of blood | 81 |
be involved in | 81 |
was no difference | 81 |
studies have shown | 81 |
the day of | 81 |
blood donors and | 81 |
all patients had | 81 |
we hypothesized that | 81 |
may lead to | 81 |
after the first | 81 |
and patients with | 81 |
and it is | 81 |
allogeneic hematopoietic cell | 81 |
to determine if | 81 |
activation of the | 80 |
the united states | 80 |
difference between the | 80 |
males and females | 80 |
toxic epidermal necrolysis | 80 |
acute gvhd was | 80 |
we evaluated the | 80 |
the bone marrow | 80 |
p disclosure of | 80 |
the specificity of | 80 |
any of the | 80 |
all of the | 80 |
and blood products | 79 |
was the most | 79 |
the potential to | 79 |
the peripheral blood | 79 |
systemic lupus erythematosus | 79 |
to the development | 79 |
the degree of | 79 |
majority of the | 79 |
retrospective analysis of | 79 |
more than one | 79 |
large number of | 79 |
chronic gvhd was | 79 |
responsible for the | 79 |
show that the | 79 |
and t cell | 79 |
in a patient | 78 |
patients were included | 78 |
of the cases | 78 |
likely to be | 78 |
indicate that the | 78 |
half of the | 78 |
have not been | 78 |
the process of | 78 |
median duration of | 78 |
differences between the | 77 |
specificity of the | 77 |
the first days | 77 |
in the second | 77 |
out of the | 77 |
were positive for | 77 |
the safety and | 77 |
impact on the | 77 |
of the same | 77 |
respiratory syndrome coronavirus | 77 |
reduce the risk | 77 |
play an important | 77 |
was performed to | 76 |
we observed that | 76 |
a dose of | 76 |
a range of | 76 |
in cases of | 76 |
observed in patients | 76 |
within the first | 76 |
in accordance with | 76 |
we aimed to | 76 |
in patients receiving | 76 |
in a large | 76 |
the effectiveness of | 76 |
with and without | 76 |
antigen presenting cells | 76 |
from the same | 76 |
the study of | 75 |
the goal of | 75 |
the group of | 75 |
the control of | 75 |
the loss of | 75 |
disease of the | 75 |
to patients with | 75 |
full donor chimerism | 75 |
role of the | 75 |
are involved in | 75 |
was treated with | 75 |
the cd t | 75 |
quality of the | 75 |
effect on the | 75 |
t and b | 75 |
in pts with | 75 |
the probability of | 75 |
and efficacy of | 75 |
of transfusion medicine | 74 |
risk of relapse | 74 |
patients are alive | 74 |
may contribute to | 74 |
compared to patients | 74 |
all of them | 74 |
in patients and | 74 |
cells of the | 74 |
for up to | 74 |
been reported to | 74 |
and class ii | 74 |
patients and methods | 74 |
significantly lower in | 74 |
has to be | 74 |
is the only | 74 |
we retrospectively analyzed | 74 |
the influence of | 74 |
for treatment of | 73 |
age of the | 73 |
in the two | 73 |
were carried out | 73 |
changes in the | 73 |
a reduction in | 73 |
all the patients | 73 |
the study period | 73 |
histocompatibility complex class | 73 |
data indicate that | 73 |
between the groups | 73 |
patients suffering from | 73 |
of patients and | 73 |
with multiple myeloma | 73 |
presence of a | 73 |
be used for | 73 |
for the presence | 73 |
the prevention of | 72 |
have been described | 72 |
be able to | 72 |
was able to | 72 |
material and methods | 72 |
died due to | 72 |
we have previously | 72 |
appear to be | 72 |
median time from | 72 |
the median number | 72 |
vitro and in | 72 |
immune responses to | 72 |
cord blood transplantation | 72 |
of cd cd | 72 |
is important to | 72 |
is an effective | 72 |
up to days | 71 |
higher risk of | 71 |
samples were collected | 71 |
can also be | 71 |
bone marrow transplant | 71 |
a retrospective analysis | 71 |
acute gvhd grade | 71 |
has been used | 71 |
were performed using | 71 |
during the study | 71 |
at years was | 71 |
hepatitis b virus | 71 |
studies are needed | 71 |
in association with | 71 |
found that the | 71 |
patients with multiple | 71 |
and the other | 71 |
needs to be | 71 |
at our center | 70 |
and platelet engraftment | 70 |
in some cases | 70 |
we conducted a | 70 |
has been found | 70 |
significant increase in | 70 |
cause of death | 70 |
in the literature | 70 |
compared to controls | 70 |
in pediatric patients | 70 |
it is important | 70 |
and for the | 70 |
for all patients | 70 |
transplant related mortality | 70 |
included in this | 70 |
samples were tested | 70 |
t cells was | 70 |
myeloablative conditioning regimen | 70 |
minimal residual disease | 70 |
was measured by | 70 |
in the united | 70 |
to that of | 70 |
of red cell | 70 |
patients were transplanted | 70 |
levels of il | 69 |
structure of the | 69 |
as a consequence | 69 |
in which the | 69 |
we did not | 69 |
was present in | 69 |
direct antiglobulin test | 69 |
disclosure of interest | 69 |
of stem cell | 69 |
considered to be | 69 |
from january to | 69 |
in recent years | 69 |
of the mhc | 69 |
there are no | 68 |
higher incidence of | 68 |
identified in the | 68 |
hiv infected cells | 68 |
the general population | 68 |
was achieved in | 68 |
cd cd cd | 68 |
time to neutrophil | 68 |
hepatitis c virus | 68 |
were no significant | 68 |
based on a | 68 |
to declare background | 68 |
the cause of | 68 |
of all patients | 68 |
was confirmed by | 68 |
performed using the | 68 |
were significantly higher | 68 |
patients who have | 68 |
the relationship between | 67 |
overall survival was | 67 |
there is an | 67 |
the formation of | 67 |
the administration of | 67 |
from whole blood | 67 |
was to determine | 67 |
the overall survival | 67 |
associated with higher | 67 |
aim was to | 67 |
in the past | 67 |
a significant increase | 66 |
t h e | 66 |
the outcomes of | 66 |
with regard to | 66 |
factors associated with | 66 |
the application of | 66 |
for at least | 66 |
identification of the | 66 |
adult patients with | 66 |
which can be | 66 |
are the most | 66 |
is known to | 66 |
in relation to | 66 |
with high risk | 66 |
t cells to | 65 |
materials and methods | 65 |
by means of | 65 |
the hypothesis that | 65 |
school of medicine | 65 |
remains to be | 65 |
been found to | 65 |
have been used | 65 |
in this case | 65 |
a period of | 65 |
blood transfusion services | 65 |
have been identified | 65 |
is essential for | 65 |
the function of | 65 |
of the two | 65 |
from diagnosis to | 65 |
of the tcr | 64 |
intensive care unit | 64 |
our study was | 64 |
the release of | 64 |
t cells that | 64 |
be considered as | 64 |
outcome of patients | 64 |
the mechanism of | 64 |
is necessary to | 64 |
in whole blood | 64 |
may not be | 64 |
with the use | 64 |
that of the | 64 |
the emergence of | 64 |
did not have | 64 |
implementation of the | 63 |
more than of | 63 |
in the serum | 63 |
led to the | 63 |
is due to | 63 |
in one patient | 63 |
been used to | 63 |
dose of mg | 63 |
cd cells were | 63 |
will be presented | 63 |
lead to a | 63 |
the first months | 63 |
all patients with | 63 |
the patient and | 63 |
the s protein | 63 |
polymerase chain reaction | 63 |
we were able | 63 |
here we report | 63 |
innate and adaptive | 63 |
disease status at | 63 |
the blood transfusion | 63 |
resulting in a | 62 |
suggesting that the | 62 |
were determined by | 62 |
were divided into | 62 |
b cells and | 62 |
the cost of | 62 |
a t cell | 62 |
is required for | 62 |
correlation between the | 62 |
an increased risk | 62 |
no evidence of | 62 |
a case of | 62 |
source of stem | 62 |
and b cells | 62 |
reported to be | 62 |
at day and | 62 |
of allogeneic hematopoietic | 62 |
was shown to | 61 |
the concentration of | 61 |
the only curative | 61 |
for more than | 61 |
of patients had | 61 |
been reported in | 61 |
the performance of | 61 |
of the skin | 61 |
lead to the | 61 |
patients were in | 61 |
no statistically significant | 61 |
were compared to | 61 |
b and c | 61 |
of at least | 61 |
the period of | 61 |
leading to the | 61 |
and it was | 61 |
the design of | 61 |
samples were taken | 61 |
prophylaxis consisted of | 61 |
we report a | 61 |
not statistically significant | 61 |
but it is | 60 |
e and e | 60 |
surface expression of | 60 |
this retrospective study | 60 |
significant differences between | 60 |
suggests that the | 60 |
have to be | 60 |
we found a | 60 |
on the cell | 60 |
cytotoxic t lymphocyte | 60 |
that there is | 60 |
flow cytometry and | 60 |
control of the | 60 |
statistically significant difference | 60 |
causes of death | 60 |
the association between | 60 |
is the author | 60 |
is involved in | 60 |
for patients who | 60 |
consistent with the | 60 |
age at transplant | 60 |
not significantly different | 60 |
cd cells kg | 60 |
to display the | 60 |
the binding of | 60 |
of hematopoietic stem | 60 |
proportion of patients | 60 |
performed in the | 60 |
a lack of | 60 |
lung transplant recipients | 60 |
be used as | 60 |
members of the | 60 |
or absence of | 60 |
the results were | 60 |
case of a | 59 |
for the patients | 59 |
was diagnosed in | 59 |
acute graft versus | 59 |
member of the | 59 |
as gvhd prophylaxis | 59 |
based on these | 59 |
was to assess | 59 |
in the majority | 59 |
of patients in | 59 |
carried out in | 59 |
a license to | 59 |
preprint in perpetuity | 59 |
display the preprint | 59 |
the response to | 59 |
extensive chronic gvhd | 59 |
added to the | 59 |
and the number | 59 |
in of cases | 59 |
expression of hla | 59 |
immune response in | 59 |
of acute rejection | 59 |
an immune response | 59 |
has granted medrxiv | 59 |
as previously described | 59 |
no differences in | 59 |
and can be | 59 |
data not shown | 59 |
weak d types | 59 |
followed by a | 59 |
license to display | 59 |
efficacy and safety | 59 |
granted medrxiv a | 59 |
study was conducted | 59 |
critically ill patients | 59 |
it can be | 59 |
the author funder | 59 |
medrxiv a license | 59 |
who has granted | 59 |
i and class | 59 |
the preprint in | 59 |
a significantly higher | 58 |
the selection of | 58 |
could be used | 58 |
addition to the | 58 |
to predict the | 58 |
is caused by | 58 |
significant difference between | 58 |
bone marrow and | 58 |
of the population | 58 |
which may be | 58 |
clinical and laboratory | 58 |
median age years | 58 |
and mycophenolate mofetil | 58 |
whole blood and | 58 |
a significant reduction | 58 |
and cd cells | 58 |
is possible to | 58 |
safety of blood | 58 |
data show that | 58 |
to bind to | 58 |
were detected by | 58 |
are summarized in | 58 |
little is known | 58 |
is able to | 58 |
no effect on | 58 |
was to investigate | 58 |
cells from the | 58 |
were isolated from | 58 |
data on the | 58 |
major cause of | 57 |
is a common | 57 |
severe combined immunodeficiency | 57 |
tumor necrosis factor | 57 |
to confirm the | 57 |
to examine the | 57 |
in line with | 57 |
during the last | 57 |
acute or chronic | 57 |
according to our | 57 |
number of blood | 57 |
a single center | 57 |
an increase of | 57 |
day and day | 57 |
similar to the | 57 |
the blood supply | 57 |
our data suggest | 57 |
one of these | 57 |
the patient is | 57 |
aim of our | 57 |
decrease in the | 57 |
days after the | 57 |
to define the | 56 |
regions of the | 56 |
the stem cell | 56 |
a set of | 56 |
and may be | 56 |
significantly higher than | 56 |
it may be | 56 |
among patients with | 56 |
and quality of | 56 |
of the drug | 56 |
has led to | 56 |
in all the | 56 |
of the major | 56 |
a large number | 56 |
use of a | 56 |
to understand the | 56 |
antibodies were detected | 56 |
in the patients | 56 |
on the day | 56 |
was supported by | 56 |
and did not | 56 |
in children and | 56 |
blood donors are | 56 |
in humanized mice | 56 |
assessment of the | 56 |
in the us | 56 |
region of the | 56 |
of severe acute | 56 |
specific for the | 56 |
could be a | 55 |
were diagnosed with | 55 |
effect of the | 55 |
bone marrow failure | 55 |
it was found | 55 |
have been developed | 55 |
demonstrated that the | 55 |
male and female | 55 |
be related to | 55 |
sensitivity and specificity | 55 |
has been associated | 55 |
unrelated cord blood | 55 |
donor and recipient | 55 |
who received a | 55 |
mutations in the | 55 |
lower in the | 55 |
to the blood | 55 |
located in the | 55 |
seem to be | 55 |
the activity of | 55 |
defined as the | 55 |
the in vitro | 55 |
with the same | 55 |
the copyright holder | 55 |
in our hospital | 55 |
cell source was | 55 |
and blood components | 55 |
the cells were | 55 |
analyses were performed | 55 |
of the cells | 55 |
high level of | 54 |
nature of the | 54 |
small number of | 54 |
the potential for | 54 |
b cell epitopes | 54 |
severe aplastic anemia | 54 |
presence or absence | 54 |
up to of | 54 |
the feasibility of | 54 |
acute lung injury | 54 |
did not show | 54 |
and the median | 54 |
led to a | 54 |
ranged from to | 54 |
is known about | 54 |
patients with chronic | 54 |
or chronic gvhd | 54 |
cd cell dose | 54 |
we have developed | 54 |
reduction of the | 54 |
further studies are | 54 |
of the graft | 54 |
performance of the | 54 |
summarized in table | 54 |
cytotoxic t cells | 54 |
the capacity of | 53 |
proved to be | 53 |
in spite of | 53 |
and peripheral blood | 53 |
c bl mice | 53 |
patients who are | 53 |
from healthy donors | 53 |
after days of | 53 |
in the immune | 53 |
and at the | 53 |
n a l | 53 |
in the other | 53 |
risk of developing | 53 |
autologous hematopoietic stem | 53 |
was added to | 53 |
to declare p | 53 |
from peripheral blood | 53 |
at high risk | 53 |
donors in the | 53 |
of platelet concentrates | 53 |
to develop a | 53 |
to estimate the | 53 |
and has been | 53 |
to respond to | 53 |
characteristics of the | 53 |
the field of | 53 |
shown in the | 53 |
presence of the | 53 |
copyright holder for | 52 |
binding to the | 52 |
were no differences | 52 |
may be associated | 52 |
has the potential | 52 |
disease free survival | 52 |
the beginning of | 52 |
low levels of | 52 |
this version posted | 52 |
data from the | 52 |
option for patients | 52 |
of morbidity and | 52 |
to be an | 52 |
results demonstrate that | 52 |
at a dose | 52 |
of the protein | 52 |
high dose chemotherapy | 52 |
and treatment of | 52 |
it is also | 52 |
high incidence of | 52 |
in the field | 52 |
with a mean | 52 |
t cell repertoire | 52 |
the range of | 52 |
infection in the | 52 |
were compared with | 52 |
to ensure that | 52 |
this preprint this | 52 |
was a significant | 52 |
for this preprint | 52 |
followed by autologous | 52 |
preprint this version | 52 |
blood group antigens | 52 |
holder for this | 52 |
and function of | 52 |
matched sibling donor | 52 |
cell responses in | 52 |
limited number of | 52 |
activity of the | 52 |
correlated with the | 52 |
of children with | 52 |
at risk of | 51 |
t cell depletion | 51 |
pediatric patients with | 51 |
at risk for | 51 |
been shown that | 51 |
memory t cell | 51 |
in the graft | 51 |
the patient had | 51 |
patients with relapsed | 51 |
after lung transplantation | 51 |
of the peptides | 51 |
may be due | 51 |
hemolytic transfusion reactions | 51 |
the study is | 51 |
abo blood group | 51 |
of the procedure | 51 |
mesenchymal stem cells | 51 |
test was used | 51 |
which is a | 51 |
and in patients | 51 |
blood components and | 51 |
revealed that the | 51 |
in this context | 51 |
the blood donors | 51 |
to test the | 51 |
were more likely | 51 |
was due to | 51 |
in the s | 51 |
standard of care | 51 |
was based on | 51 |
the start of | 51 |
that have been | 51 |
peptides derived from | 51 |
we demonstrate that | 50 |
with an increased | 50 |
matched unrelated donors | 50 |
on the contrary | 50 |
matched related donor | 50 |
complex class i | 50 |
results in a | 50 |
in univariate analysis | 50 |
and one patient | 50 |
the fi rst | 50 |
were performed on | 50 |
than that of | 50 |
were performed with | 50 |
on day after | 50 |
blood donors were | 50 |
in both the | 50 |
in the patient | 50 |
our results show | 50 |
had to be | 50 |
allogeneic bone marrow | 50 |
course of the | 50 |
used to determine | 50 |
mean age of | 50 |
were transplanted in | 50 |
bone marrow in | 50 |
one patient died | 50 |
white blood cells | 50 |
is mediated by | 50 |
were measured by | 50 |
did not receive | 50 |
and nk cells | 50 |
impact of the | 50 |
which could be | 50 |
the initiation of | 50 |
of these cells | 50 |
the interaction between | 50 |
was analyzed by | 49 |
and cord blood | 49 |
in the following | 49 |
progression free survival | 49 |
and number of | 49 |
days of storage | 49 |
the primary endpoint | 49 |
are known to | 49 |
and development of | 49 |
of the four | 49 |
a risk factor | 49 |
function of the | 49 |
the incidence and | 49 |
in bone marrow | 49 |
from unrelated donors | 49 |
and mortality in | 49 |
a diagnosis of | 49 |
up was months | 49 |
in a cohort | 49 |
a mean of | 49 |
of the s | 49 |
cells as well | 49 |
of the different | 49 |
was not significantly | 49 |
was evaluated by | 49 |
year cumulative incidence | 49 |
one patient with | 49 |
donor t cells | 49 |
the mean age | 49 |
dependent on the | 49 |
for these patients | 49 |
of patients was | 49 |
similar to that | 49 |
and should be | 49 |
was identified in | 49 |
study of the | 49 |
of b cells | 49 |
the evaluation of | 49 |
results showed that | 49 |
to characterize the | 49 |
the extent of | 49 |
peripheral blood of | 49 |
a significant difference | 49 |
were excluded from | 48 |
have also been | 48 |
associated with high | 48 |
and months after | 48 |
to be more | 48 |
and cd cd | 48 |
os and pfs | 48 |
from an hla | 48 |
is thought to | 48 |
a statistically significant | 48 |
gvhd prophylaxis was | 48 |
we compared the | 48 |
were subjected to | 48 |
it is a | 48 |
well as a | 48 |
for prediction of | 48 |
cell epitopes in | 48 |
cell response to | 48 |
bacterial contamination of | 48 |
cell transplantation is | 48 |
the group with | 48 |
be used in | 48 |
the interaction of | 48 |
the need to | 48 |
gvhd prophylaxis consisted | 48 |
clinical trial registry | 48 |
when compared with | 48 |
of which were | 48 |
of the anti | 48 |
time of the | 48 |
in the regulation | 48 |
cells and the | 48 |
in our institution | 48 |
at last follow | 48 |
in the plasma | 48 |
a year old | 48 |
the median duration | 48 |
are alive and | 48 |
allogeneic haematopoietic stem | 48 |
performed in patients | 48 |
of more than | 48 |
adaptive immune responses | 48 |
caused by the | 48 |
an unrelated donor | 48 |
high risk patients | 48 |
thought to be | 48 |
of the rhd | 48 |
specific cytotoxic t | 48 |
we showed that | 47 |
was not statistically | 47 |
the collection of | 47 |
of the host | 47 |
in recipients of | 47 |
regimen consisted of | 47 |
to those of | 47 |
during the course | 47 |
of b cell | 47 |
blood donation and | 47 |
response to a | 47 |
it is known | 47 |
intensity conditioning regimen | 47 |
at transplant was | 47 |
a role for | 47 |
acute gvhd and | 47 |
we examined the | 47 |
only one patient | 47 |
as compared with | 47 |
and cd cell | 47 |
in group a | 47 |
with the median | 47 |
whole blood donors | 47 |
of the national | 47 |
with a higher | 47 |
patients with hematological | 47 |
are present in | 47 |
depends on the | 47 |
resulted in the | 47 |
in the liver | 47 |
required for the | 47 |
the efficiency of | 47 |
status of the | 47 |
and after the | 47 |
did not affect | 47 |
in the peripheral | 47 |
can be a | 46 |
is needed to | 46 |
the first step | 46 |
in this patient | 46 |
we demonstrated that | 46 |
only in the | 46 |
efficacy of the | 46 |
and management of | 46 |
the source of | 46 |
were performed by | 46 |
p r o | 46 |
with an average | 46 |
the volume of | 46 |
transplantation in patients | 46 |
of graft failure | 46 |
t cell immunity | 46 |
in patients treated | 46 |
with the exception | 46 |
higher in patients | 46 |
levels of the | 46 |
incidence of grade | 46 |
there has been | 46 |
the increase in | 46 |
center background case | 46 |
herpes simplex virus | 46 |
results in the | 46 |
we suggest that | 46 |
analysis showed that | 46 |
cells can be | 46 |
with bone marrow | 46 |
was applied to | 46 |
the in vivo | 46 |
for blood donation | 46 |
be explained by | 46 |
in the period | 46 |
to donate blood | 46 |
of blood group | 46 |
prior to hsct | 46 |
that may be | 46 |
for the same | 46 |
in the diagnosis | 46 |
the determination of | 46 |
found to have | 46 |
months after hsct | 46 |
in the human | 46 |
stem cell mobilization | 46 |
the innate immune | 46 |
has been suggested | 46 |
is not a | 46 |
that could be | 46 |
both cd and | 46 |
reduction in the | 46 |
stored for days | 46 |
with a low | 46 |
have demonstrated that | 46 |
of the clinical | 46 |
haploidentical stem cell | 46 |
had no effect | 46 |
is safe and | 46 |
of grade ii | 45 |
conditioning regimen consisted | 45 |
increased expression of | 45 |
colony stimulating factor | 45 |
are required to | 45 |
in the transfusion | 45 |
and type of | 45 |
in this group | 45 |
has been demonstrated | 45 |
class i binding | 45 |
the major histocompatibility | 45 |
hemolytic disease of | 45 |
stem cells in | 45 |
the frequencies of | 45 |
we sought to | 45 |
at this time | 45 |
the current study | 45 |
the mhc i | 45 |
the remaining patients | 45 |
the basis for | 45 |
the result of | 45 |
the median of | 45 |
fludarabine mg m | 45 |
of the fetus | 45 |
carried out by | 45 |
of red cells | 45 |
our results suggest | 45 |
on days and | 45 |
to be used | 45 |
for gvhd prophylaxis | 45 |
these results indicate | 45 |
the establishment of | 45 |
follow up was | 45 |
the results obtained | 45 |
months after the | 45 |
sequence of the | 45 |
indirect antiglobulin test | 45 |
this work was | 45 |
more common in | 45 |
conditioning regimen for | 45 |
chronic granulomatous disease | 45 |
were defined as | 45 |
epitopes in the | 45 |
to prevent the | 44 |
used to identify | 44 |
may also be | 44 |
was significantly associated | 44 |
by using the | 44 |
in the current | 44 |
blood samples from | 44 |
and the presence | 44 |
have been found | 44 |
the cd cd | 44 |
were present in | 44 |
and the use | 44 |
patients affected by | 44 |
amino acid sequence | 44 |
performed on the | 44 |
risk of transfusion | 44 |
similar to those | 44 |
higher than the | 44 |
patients who developed | 44 |
the exception of | 44 |
to our knowledge | 44 |
of acute and | 44 |
that in the | 44 |
a safe and | 44 |
x cd cells | 44 |
in most cases | 44 |
a review of | 44 |
in vivo and | 44 |
cd cells in | 44 |
time of transplant | 44 |
peripheral blood in | 44 |
higher levels of | 44 |
in t cells | 44 |
with acute leukemia | 44 |
the prediction of | 44 |
the need of | 44 |
the mechanisms of | 44 |
with acute myeloid | 44 |
determined by the | 44 |
is used to | 44 |
h n influenza | 44 |
blood transfusion is | 44 |
significant difference was | 44 |
high rate of | 44 |
the appearance of | 44 |
characterized by a | 44 |
was designed to | 44 |
of the cell | 44 |
and in vitro | 44 |
year os was | 43 |
of class i | 43 |
the presence or | 43 |
t cells by | 43 |
e l l | 43 |
due to anti | 43 |
is shown in | 43 |
immunodeficiency virus type | 43 |
and b cell | 43 |
of the three | 43 |
the capacity to | 43 |
in the lung | 43 |
findings suggest that | 43 |
neutrophil engraftment was | 43 |
review of the | 43 |
were evaluated for | 43 |
may be an | 43 |
was not associated | 43 |
should not be | 43 |
at least two | 43 |
in the management | 43 |
months after transplantation | 43 |
in our experience | 43 |
has been described | 43 |
the blood donation | 43 |
class i mhc | 43 |
peripheral blood and | 43 |
by t cells | 43 |
were identified in | 43 |
the nature of | 43 |
in the production | 43 |
ministry of health | 43 |
that the use | 43 |
patients with active | 43 |
is important for | 43 |
for blood transfusion | 43 |
cd cd cells | 43 |
we have shown | 43 |
no difference between | 43 |
in the thymus | 43 |
inflammatory bowel disease | 43 |
one of them | 43 |
for use in | 43 |
red cell units | 43 |
the serum of | 43 |
we present a | 43 |
of the antigen | 43 |
over the last | 43 |
were incubated with | 43 |
time from diagnosis | 43 |
significant reduction of | 43 |
in adult patients | 43 |
to the patient | 43 |
and could be | 43 |
patients with mm | 43 |
is related to | 43 |
and use of | 43 |
in one case | 43 |
treatment option for | 43 |
the amino acid | 43 |
reactive t cells | 43 |
and severity of | 43 |
cyclophosphamide mg kg | 43 |
national blood transfusion | 43 |
university school of | 43 |
is to evaluate | 43 |
processing and presentation | 43 |
for detection of | 43 |
in the course | 43 |
wide range of | 43 |
leads to the | 43 |
high frequency of | 43 |
factors such as | 42 |
quality of blood | 42 |
p r e | 42 |
in the hla | 42 |
treatment of patients | 42 |
effector t cells | 42 |
t cell lines | 42 |
as measured by | 42 |
basis of the | 42 |
it was shown | 42 |
it should be | 42 |
tests were performed | 42 |
patients with sle | 42 |
the patients received | 42 |
higher number of | 42 |
red cell concentrates | 42 |
class i alleles | 42 |
the dose of | 42 |
in patients after | 42 |
world health organization | 42 |
response in the | 42 |
the choice of | 42 |
on day of | 42 |
with a history | 42 |
blood and marrow | 42 |
may play a | 42 |
regulation of the | 42 |
presence of anti | 42 |
in this setting | 42 |
development of the | 42 |
of the vaccine | 42 |
as an alternative | 42 |
pre and post | 42 |
supported by the | 42 |
vg vd t | 42 |
in the population | 42 |
in the t | 42 |
in the spleen | 42 |
reported in the | 42 |
is dependent on | 42 |
in the induction | 42 |
cells specific for | 42 |
t cells specific | 42 |
was obtained from | 42 |
during the period | 42 |
the results are | 42 |
a consequence of | 42 |
the size of | 42 |
to measure the | 42 |
there have been | 42 |
of the hiv | 42 |
this may be | 42 |
overall survival in | 42 |
comparison of the | 42 |
safety of the | 42 |
the kinetics of | 41 |
in the clinical | 41 |
has been developed | 41 |
patients did not | 41 |
free survival was | 41 |
these results demonstrate | 41 |
in the process | 41 |
overall survival and | 41 |
size of the | 41 |
the efficacy and | 41 |
patients have been | 41 |
an attempt to | 41 |
were selected for | 41 |
the length of | 41 |
the patients had | 41 |
and the mean | 41 |
binding to mhc | 41 |
patient blood management | 41 |
period of time | 41 |
was lower in | 41 |
the sensitivity of | 41 |
engraftment was days | 41 |
was found that | 41 |
with the highest | 41 |
of the newborn | 41 |
positive for anti | 41 |
in our cohort | 41 |
goal of this | 41 |
melphalan mg m | 41 |
were measured in | 41 |
primary graft failure | 41 |
due to its | 41 |
the value of | 41 |
levels of cd | 41 |
donors with a | 41 |
is responsible for | 41 |
autologous peripheral blood | 41 |
on behalf of | 41 |
and identification of | 41 |
study was performed | 41 |
of all the | 41 |
as early as | 41 |
was detected by | 41 |
at the moment | 41 |
in blood transfusion | 41 |
in our centre | 41 |
been observed in | 41 |
cd cell count | 41 |
of the recipient | 41 |
data were collected | 41 |
car t cells | 41 |
the ratio of | 41 |
the concept of | 41 |
were enrolled in | 41 |
a critical role | 41 |
determination of the | 41 |
at the beginning | 41 |
of the other | 41 |
was the only | 41 |
of patients receiving | 41 |
used to evaluate | 41 |
kg body weight | 41 |
treated with a | 41 |
in more than | 40 |
related or unrelated | 40 |
expressed on the | 40 |
memory b cells | 40 |
of patients are | 40 |
cells and cd | 40 |
have been observed | 40 |
for children with | 40 |
have developed a | 40 |
well as to | 40 |
the existence of | 40 |
were due to | 40 |
secondary graft failure | 40 |
blood donors with | 40 |
contrast to the | 40 |
blood donors is | 40 |
serum levels of | 40 |
to present the | 40 |
is used for | 40 |
in this cohort | 40 |
the class i | 40 |
the presentation of | 40 |
cd or cd | 40 |
more frequent in | 40 |
all patients engrafted | 40 |
which has been | 40 |
the difference between | 40 |
immune response and | 40 |
diffuse large b | 40 |
activated t cells | 40 |
over a period | 40 |
severe chronic gvhd | 40 |
a part of | 40 |
is capable of | 40 |
ranging from to | 40 |
was found between | 40 |
is defined as | 40 |
c e l | 40 |
were analyzed for | 40 |
demonstrate that the | 40 |
serve as a | 40 |
that it is | 40 |
in our series | 40 |
o u r | 40 |
is used in | 40 |
on the use | 40 |
the discovery of | 40 |
may have a | 40 |
at least in | 40 |
with hematological malignancies | 40 |
to elucidate the | 40 |
epitopes of the | 40 |
patients with an | 40 |
to be involved | 40 |
and h n | 40 |
of the conditioning | 40 |
cytotoxic t cell | 40 |
increased susceptibility to | 40 |
patients undergoing allogeneic | 40 |
the national blood | 40 |
of infectious diseases | 40 |
and that the | 40 |
independently associated with | 40 |
one patient had | 40 |
blood donors who | 40 |
surface of the | 40 |
the most commonly | 40 |
group and in | 40 |
shown that the | 40 |
in the a | 40 |
of the following | 40 |
a trend towards | 40 |
cause of morbidity | 40 |
of the present | 40 |
a is the | 40 |
in the uk | 40 |
after hematopoietic stem | 40 |
of a new | 40 |
results of a | 40 |
performed a retrospective | 40 |
was diagnosed with | 40 |
of death were | 40 |
of overall survival | 40 |
of the use | 39 |
antibodies in the | 39 |
been implicated in | 39 |
the red cell | 39 |
the most frequently | 39 |
ifitm double null | 39 |
patients diagnosed with | 39 |
cell activation and | 39 |
for min at | 39 |
of the a | 39 |
expression in the | 39 |
we have recently | 39 |
platelet engraftment was | 39 |
and had a | 39 |
differences were observed | 39 |
compared to non | 39 |
respect to the | 39 |
among the patients | 39 |
were added to | 39 |
was peripheral blood | 39 |
of the data | 39 |
is required to | 39 |
is a significant | 39 |
are likely to | 39 |
was not observed | 39 |
in the general | 39 |
seen in the | 39 |
divided into two | 39 |
the contribution of | 39 |
have been associated | 39 |
essential for the | 39 |
were similar in | 39 |
of the ebmt | 39 |
cell epitopes of | 39 |
of the new | 39 |
has been observed | 39 |
compared to a | 39 |
a marker of | 39 |
a l p | 39 |
t cells is | 39 |
in severe covid | 39 |
r n a | 39 |
the success of | 39 |
of the viral | 39 |
we used a | 39 |
class i antigens | 39 |
are required for | 39 |
units of blood | 39 |
components of the | 39 |
ifitm ifitm double | 39 |
at months after | 39 |
for the prevention | 39 |
were identified as | 39 |
the vast majority | 39 |
to better understand | 39 |
do not have | 39 |
the maintenance of | 39 |
due to their | 39 |
not differ between | 39 |
distribution of the | 39 |
the central nervous | 39 |
of a single | 39 |
who underwent allogeneic | 39 |
nk cells in | 39 |
statistical analysis was | 39 |
in patients without | 39 |
similar in both | 39 |
were not significantly | 39 |
hsct in our | 39 |
to ensure the | 39 |
to detect the | 39 |
from blood donors | 39 |
after allogeneic hsct | 39 |
the potential of | 39 |
vast majority of | 39 |
we used the | 39 |
of cmv reactivation | 39 |
plays an important | 39 |
class i molecule | 39 |
isolated from the | 39 |
responses to the | 39 |
for each of | 39 |
in those with | 39 |
immune responses in | 39 |
adverse events were | 39 |
from the blood | 39 |
for the entire | 39 |
some of these | 39 |
most of them | 38 |
american red cross | 38 |
from bone marrow | 38 |
days after hsct | 38 |
main cause of | 38 |
approved by the | 38 |
the risk for | 38 |
patients with the | 38 |
immune response against | 38 |
may be used | 38 |
a matched unrelated | 38 |
of them had | 38 |
chronic gvhd and | 38 |
patients transplanted from | 38 |
in two patients | 38 |
which was not | 38 |
therapy in patients | 38 |
over the past | 38 |
t cell recognition | 38 |
the site of | 38 |
characterization of the | 38 |
chronic graft versus | 38 |
the spike protein | 38 |
at the university | 38 |
we developed a | 38 |
of cmv infection | 38 |
for the study | 38 |
and days after | 38 |
together with the | 38 |
increased in the | 38 |
shown in fig | 38 |
the most effective | 38 |
the donor was | 38 |
were transplanted from | 38 |
to play a | 38 |
of the samples | 38 |
in the non | 38 |
with the aim | 38 |
gvhd grade ii | 38 |
patients with advanced | 38 |
may result in | 38 |
the reduction of | 38 |
kidney transplant recipients | 38 |
human t cell | 38 |
were cultured in | 38 |
the host immune | 38 |
as in the | 38 |
to the mhc | 38 |
but also in | 38 |
in the multivariate | 38 |
adoptive transfer of | 38 |
high density multiepitope | 38 |
while in the | 38 |
patients with agvhd | 38 |
epitopes derived from | 38 |
in blood and | 38 |
after stem cell | 38 |
of immune responses | 38 |
was positive in | 38 |
were collected and | 38 |
of the il | 38 |
this suggests that | 38 |
in some patients | 38 |
was to analyze | 38 |
we have identified | 38 |
to enhance the | 38 |
for the diagnosis | 38 |
of patients received | 38 |
of cd b | 38 |
linked to the | 38 |
common cause of | 38 |
who underwent allo | 38 |
on the outcome | 38 |
significantly lower than | 38 |
the transfusion of | 38 |
in a dose | 38 |
as a potential | 38 |
study aimed to | 38 |
amino acid sequences | 37 |
was to compare | 37 |
voluntary blood donors | 37 |
of the liver | 37 |
were identified by | 37 |
these patients were | 37 |
is not known | 37 |
survival in patients | 37 |
using flow cytometry | 37 |
significantly different between | 37 |
r o o | 37 |
to explore the | 37 |
innate immune system | 37 |
of adverse events | 37 |
conditioning regimens were | 37 |
a high level | 37 |
is essential to | 37 |
u r n | 37 |
incidence of chronic | 37 |
quality and safety | 37 |
can be detected | 37 |
frequency of the | 37 |
relapsed or refractory | 37 |
platelets stored at | 37 |
cells in a | 37 |
we hypothesize that | 37 |
the samples were | 37 |
this group of | 37 |
is made available | 37 |
a significant proportion | 37 |
described in the | 37 |
of a novel | 37 |
in vitro studies | 37 |
to validate the | 37 |
the data of | 37 |
by the presence | 37 |
and with the | 37 |
positive and negative | 37 |
a key role | 37 |
used to assess | 37 |
by cd t | 37 |
reported to the | 37 |
patients who did | 37 |
referred to as | 37 |
mean number of | 37 |
significant impact on | 37 |
at the age | 37 |
blood products and | 37 |
to describe the | 37 |
used in patients | 37 |
most common cause | 37 |
phase of the | 37 |
l p r | 37 |
mainly due to | 37 |
change in the | 37 |
results of this | 37 |
the preparation of | 37 |
donor lymphocyte infusion | 37 |
is found in | 37 |
a reduced intensity | 37 |
the blood group | 37 |
in the skin | 37 |
of our patients | 37 |
j o u | 37 |
and the development | 37 |
cd cells was | 37 |
for the blood | 37 |
we have been | 37 |
as the most | 37 |
based on this | 37 |
predicted to be | 37 |
and of patients | 37 |
o o f | 37 |
were evaluated by | 37 |
chronic gvhd were | 36 |
are presented in | 36 |
on t cell | 36 |
probably due to | 36 |
has been identified | 36 |
patients with covid | 36 |
resulting in the | 36 |
of the epitope | 36 |
data demonstrate that | 36 |
significant decrease in | 36 |
response to treatment | 36 |
the patients was | 36 |
were shown to | 36 |
primary and secondary | 36 |
insights into the | 36 |
in cases with | 36 |
patients had received | 36 |
compared to control | 36 |
we studied the | 36 |
compared to other | 36 |
we tested the | 36 |
and dendritic cells | 36 |
used in this | 36 |
the world health | 36 |
less than of | 36 |
and duration of | 36 |
patients at risk | 36 |
large numbers of | 36 |
it is made | 36 |
with the development | 36 |
diseases such as | 36 |
in the analysis | 36 |
accordance with the | 36 |
results from the | 36 |
in cd t | 36 |
renal transplant recipients | 36 |
outcome of the | 36 |
a wide range | 36 |
who had received | 36 |
of the results | 36 |
the stability of | 36 |
be effective in | 36 |
and of them | 36 |
showed a significant | 36 |
the red blood | 36 |
t cells can | 36 |
significant proportion of | 36 |
a source of | 36 |
in the pre | 36 |
mg m day | 36 |
results were obtained | 36 |
we report on | 36 |
with an increase | 36 |
binding affinity to | 36 |
was higher than | 36 |
a crucial role | 36 |
we decided to | 36 |
a member of | 36 |
the risk factors | 36 |
and adaptive immune | 36 |
the characteristics of | 36 |
with the hla | 36 |
fold increase in | 36 |
or in combination | 36 |
scansystem tm platelet | 36 |
to the cell | 36 |
that did not | 36 |
t cell subsets | 36 |
age at hsct | 36 |
of less than | 36 |
clinically significant antibodies | 36 |
a higher risk | 36 |
tm platelet kit | 36 |
sensitivity of the | 36 |
in this population | 36 |
of the antibody | 36 |
we believe that | 36 |
of autologous blood | 36 |
of up to | 36 |
percentage of cd | 36 |
is known that | 36 |
recognized by the | 36 |
university medical center | 36 |
in this analysis | 36 |
in a multivariate | 36 |
allowed us to | 36 |
the form of | 36 |
were negative for | 36 |
whether or not | 35 |
for blood and | 35 |
to achieve a | 35 |
many of the | 35 |
the entire cohort | 35 |
be an effective | 35 |
was reported in | 35 |
b and t | 35 |
age of patients | 35 |
than of the | 35 |
along with the | 35 |
the main cause | 35 |
statistically significant differences | 35 |
serious adverse events | 35 |
testing was performed | 35 |
higher than that | 35 |
were analysed by | 35 |
severity of the | 35 |
the department of | 35 |
and response to | 35 |
a n t | 35 |
but not the | 35 |
cd cells from | 35 |
blood group systems | 35 |
validation of the | 35 |
of the high | 35 |
enrolled in the | 35 |
in this retrospective | 35 |
conditioning regimen and | 35 |
one patient developed | 35 |
were analyzed using | 35 |
significant reduction in | 35 |
were the most | 35 |
transfusion medicine and | 35 |
transplanted in cr | 35 |
of the pts | 35 |
may be the | 35 |
order to evaluate | 35 |
used to predict | 35 |
autoimmune hemolytic anemia | 35 |
performed according to | 35 |
had a significantly | 35 |
in at least | 35 |
and stem cell | 35 |
the immunogenicity of | 35 |
there are two | 35 |
of the world | 35 |
been described in | 35 |
with at least | 35 |
whole blood units | 35 |
of bacterial contamination | 35 |
neonatal alloimmune thrombocytopenia | 35 |
with more than | 35 |
has resulted in | 35 |
from a matched | 35 |
for transfusion medicine | 35 |
university hospital of | 35 |
domain of the | 35 |
and compared to | 35 |
as a model | 35 |
of hla alleles | 35 |
autologous blood donation | 35 |
the infusion of | 35 |
these data indicate | 35 |
mutation in the | 35 |
considered as a | 35 |
shows that the | 35 |
chronic myeloid leukemia | 35 |
we describe the | 35 |
significant differences were | 35 |
had a positive | 35 |
the time to | 35 |
among blood donors | 35 |
distribution of blood | 35 |
associated with lower | 35 |
g dl and | 35 |
high expression of | 35 |
incidence of agvhd | 35 |
t cells of | 35 |
cord blood units | 35 |
the patients in | 35 |
in critically ill | 35 |
an alternative to | 35 |
by a single | 35 |
have been performed | 35 |
resulted in an | 35 |
and the remaining | 35 |
patients were enrolled | 35 |
autologous and allogeneic | 35 |
of relapse was | 35 |
acute myeloid leukaemia | 35 |
first time donors | 35 |
of the infection | 35 |
quality control of | 35 |
blood donation is | 35 |
indicated that the | 35 |
the possibility that | 35 |
were higher in | 35 |
the adaptive immune | 35 |
a significant decrease | 35 |
information on the | 35 |
on day was | 35 |
bind to the | 35 |
is also a | 35 |
properties of the | 35 |
of the d | 35 |
is a well | 35 |
of the main | 35 |
of mice with | 35 |
retrospective review of | 35 |
up to years | 35 |
overall survival of | 35 |
of factor viii | 35 |
the patient received | 35 |
and activation of | 35 |
be considered in | 35 |
council of europe | 35 |
to meet the | 35 |
high degree of | 34 |
that the number | 34 |
average number of | 34 |
by the use | 34 |
therapeutic plasma exchange | 34 |
regardless of the | 34 |
focused on the | 34 |
to the treatment | 34 |
not seem to | 34 |
overall response rate | 34 |
derived from a | 34 |
older than years | 34 |
antigen processing and | 34 |
a reduction of | 34 |
of the whole | 34 |
natural killer cells | 34 |
for the generation | 34 |
these results are | 34 |
lilrb d d | 34 |
conclude that the | 34 |
nk cells and | 34 |
observed that the | 34 |
cd cells and | 34 |
previous studies have | 34 |
the significance of | 34 |
or in the | 34 |
in the post | 34 |
the donors were | 34 |
the past years | 34 |
of the above | 34 |
production of il | 34 |
days after transplantation | 34 |
to analyse the | 34 |
in the form | 34 |
the structure of | 34 |
order to prevent | 34 |
red cross blood | 34 |
antigens in the | 34 |
difference was found | 34 |
of pts with | 34 |
may be useful | 34 |
peptide binding to | 34 |
the proliferation of | 34 |
high prevalence of | 34 |
patients with refractory | 34 |
a and hla | 34 |
and with a | 34 |
s and s | 34 |
was a trend | 34 |
by use of | 34 |
donor lymphocyte infusions | 34 |
length of stay | 34 |
positive results were | 34 |
with the presence | 34 |
was similar in | 34 |
mice immunized with | 34 |
mobilized peripheral blood | 34 |
single center experience | 34 |
was observed with | 34 |
international license it | 34 |
a major cause | 34 |
a myeloablative conditioning | 34 |
work was supported | 34 |
of relapse and | 34 |
made available under | 34 |
binding of the | 34 |
no conflict of | 34 |
and lack of | 34 |
amino acid residues | 34 |
can be achieved | 34 |
under a is | 34 |
of gvhd and | 34 |
for all the | 34 |
available under a | 34 |
to have the | 34 |
better understanding of | 34 |
able to induce | 34 |
to monitor the | 34 |
compared with those | 34 |
in the world | 34 |
the t cells | 34 |
license it is | 34 |
treatment of the | 34 |
the accumulation of | 34 |
is expected to | 34 |
in this work | 34 |
to cd t | 34 |
shown to have | 34 |
increased risk for | 34 |
stem cells from | 34 |
especially in the | 34 |
in our blood | 34 |
of these two | 34 |
delta t cells | 34 |
determined to be | 34 |
immune epitope database | 34 |
and the patient | 34 |
stem cells were | 34 |
in group b | 34 |
cd cd t | 34 |
we have found | 34 |
has shown that | 34 |
all but one | 34 |
found in patients | 34 |
in the bone | 34 |
and mhc class | 34 |
duration of the | 34 |
was observed between | 34 |
abstract already published | 34 |
not able to | 34 |
for h at | 34 |
the recognition of | 33 |
cell proliferation and | 33 |
time of days | 33 |
of regulatory t | 33 |
so as to | 33 |
two patients with | 33 |
blood products is | 33 |
the reasons for | 33 |
of units of | 33 |
immune responses and | 33 |
a prospective study | 33 |
is similar to | 33 |
has been proposed | 33 |
each of these | 33 |
and outcome of | 33 |
stability of the | 33 |
hsct in patients | 33 |
in multiple myeloma | 33 |
is not yet | 33 |
the rest of | 33 |
in of them | 33 |
was confirmed in | 33 |
cellular immune responses | 33 |
is feasible and | 33 |
the cord blood | 33 |
abo and rh | 33 |
focus on the | 33 |
we are currently | 33 |
occurred in the | 33 |
has been the | 33 |
the last decade | 33 |
in the recipient | 33 |
even in the | 33 |
the fetus and | 33 |
the difference in | 33 |
of the plasma | 33 |
according to their | 33 |
time of transplantation | 33 |
and treated with | 33 |
of the method | 33 |
were classified as | 33 |
shown in figure | 33 |
is a key | 33 |
packed red blood | 33 |
were screened for | 33 |
can be found | 33 |
is still a | 33 |
was performed for | 33 |
to the same | 33 |
for the whole | 33 |
developed acute gvhd | 33 |
after bone marrow | 33 |
these findings suggest | 33 |
were transfused with | 33 |
in patients transplanted | 33 |
human papillomavirus type | 33 |
the quality and | 33 |
were in cr | 33 |
in the whole | 33 |
study shows that | 33 |
did not reach | 33 |
donors and recipients | 33 |
children and adolescents | 33 |
was well tolerated | 33 |
indicates that the | 33 |
for t cell | 33 |
treatment related mortality | 33 |
of t lymphocytes | 33 |
significantly increased in | 33 |
was also observed | 33 |
of cases of | 33 |
outcomes of patients | 33 |
who underwent hsct | 33 |
was performed at | 33 |
mg kg d | 33 |
the multivariate analysis | 33 |
for the identification | 33 |
objective was to | 33 |
at day after | 33 |
we describe a | 33 |
for this purpose | 33 |
evaluate the impact | 33 |
were transplanted with | 33 |
bone marrow cells | 33 |
patients with hematologic | 33 |
of hepatitis b | 33 |
the expansion of | 33 |
cov s protein | 33 |
were tested by | 33 |
we have used | 33 |
were conditioned with | 33 |
treated with the | 33 |
of the current | 33 |
residues in the | 33 |
after blood donation | 33 |
for cd t | 33 |
could be detected | 33 |
none of them | 33 |
with a positive | 33 |
risk of graft | 33 |
in clinical practice | 33 |
effects of the | 33 |
cells with a | 33 |
had a significant | 33 |
conducted a retrospective | 33 |